Literature DB >> 4871347

Persistence of immunogenicity of two complex antigens retained in vivo.

S Britton, T Wepsic, G Möller.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4871347      PMCID： PMC1409385     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  8 in total

1.  Immunogenic sub-cellular particles obtained from spleens of antigen-injected mice.

Authors:  R E FRANZL
Journal:  Nature       Date:  1962-08-04       Impact factor: 49.962

2.  Modification of the immune response by radiation and cortisone.

Authors:  W H TALIAFERRO
Journal:  Ann N Y Acad Sci       Date:  1957-12-16       Impact factor: 5.691

3.  Biological properties of polysaccharidelipid complexes obtained from Serratia marcescens and Escherichia coli.

Authors:  H J CREECH; R F HANKWITZ
Journal:  Cancer Res       Date:  1954-12       Impact factor: 12.701

4.  Studies of the retention and properties of S35 labeled antigen in livers of immunized rabbits.

Authors:  J S GARVEY; D H CAMPBELL
Journal:  J Immunol       Date:  1956-01       Impact factor: 5.422

5.  Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency.

Authors:  D W Dresser; D H Wortis
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

6.  Immunogenicity of human serum albumin: decay in the normal mouse.

Authors:  S Britton; F Celada
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

7.  Studies at the cellular level of the 19S immune response.

Authors:  H Wigzell; G Möller; B Andersson
Journal:  Acta Pathol Microbiol Scand       Date:  1966

8.  ANTIBODY SYNTHESIS AT THE CELLULAR LEVEL. ANTIBODY-INDUCED SUPPRESSION OF 19S AND 7S ANTIBODY RESPONSE.

Authors:  G MOLLER; H WIGZELL
Journal:  J Exp Med       Date:  1965-06-01       Impact factor: 14.307
  8 in total
  18 in total

1.  Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Relationship of antigen dose to heightened primary and secondary immune responses to sheep red blood cells.

Authors:  D J Yashphe
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

2.  The primary immune response in mice. 3. Retention of sheep red blood cell immunogens by the spleen and liver.

Authors:  R E Franzl
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

3.  The orientation of the adjuvant activities of Salmonella typhosa lipopolysaccharide and lentinan.

Authors:  D W Dresser; J M Phillips
Journal:  Immunology       Date:  1974-11       Impact factor: 7.397

4.  A cyclical appearance of antibody-producing cells after a single injection of serum protein antigen.

Authors:  C G Romball; W O Weigle
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

5.  The influence of epitope density on the immunological properties of hapten-protein conjugates. II. The in vivo and in vitro metabolism of heavily and lightly conjugated protein.

Authors:  G G Klaus; G F Mitchell
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

6.  Regulation of antibody synthesis against Escherichia coli endotoxin. II. Specificity, dose requirements and duration of paralysis induced in adult mice.

Authors:  S Britton
Journal:  Immunology       Date:  1969-04       Impact factor: 7.397

7.  The immunogenicity of phagocytosed T4 bacteriophage: cell replacement studies with splenectomized and irradiated mice.

Authors:  C J Inchley; J G Howard
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

8.  Immunogenicity of human serum albumin: decay in the normal mouse.

Authors:  S Britton; F Celada
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

9.  Cell-bound helper and suppressor factors in primate lymphocytes.

Authors:  T Lehner; J R Lamb; S Kontiainen
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

10.  Antigen presentation as a factor in the protective immune response to renal infection.

Authors:  T E Miller; S Burnham
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.